Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Capitan Silver Recognized as a Top 50 TSX Venture Exchange Company
-
Great Pacific Gold Provides Drilling Update at Wild Dog Project
-
Oreterra Announces Further Over-Subscription and Upsizing of Non-Brokered Private Placement to $9 Million
-
Enduro Metals Identifies New Gold Skarn in Bedrock, Expands 5.5 km Gold-Copper Target at October Dome Project, BC
-
CEO.CA's Inside the Boardroom: PlasCred Turns Landfill Plastic into High-Value Petrochemicals for Circular Reuse Back into Valuable New Products
-
Cheelcare Closes $1.0 Million Unsecured Note Financing
-
TenX Acquires Additional Solana (SOL) and Delegates to BONK Validator to Support Ecosystem Growth
-
Pacifica Silver Reports Additional Drill Results at Claudia with Multiple High-Grade Silver-Gold Intercepts at the Aguilareña Area
-
Quimbaya Gold Advances Multi-Target Exploration at Tahami Project, Segovia
-
StrikePoint Gold Acquires Nevada's Past Producing Como Mining District from Newmont Mining Corporation
-
Chesapeake Gold Named in 2026 TSX Venture 50 List of Top Performing Companies
-
HYLQ Strategy Corp. Announces Strategic Investment in qLABS and Purchase of qONE Tokens
-
Anteros Metals Provides Operational Update on Phase 1 Extension Drilling at the Seagull Critical Minerals Project, Ontario
-
Cerrado Gold Recognized as Top 50 TSX Venture Exchange Company
-
Streamex Announces Official Launch Date of GLDY, a Yield Bearing Gold-Backed Tokenized Security
-
HUMAIN Backs xAI with $3 Billion Series E Investment Ahead of Historic SpaceX Merger
-
Pasinex Announces Q4 2025 Financial Results
-
QGold Reports Results from Its Drilling Campaigns at Its Mine Centre Gold Project
-
LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE
-
Apollo Silver Ranks 13th Overall in the 2026 TSX Venture 50™
-
SolarEdge Announces Fourth Quarter and Full Year 2025 Financial Results
-
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer
-
Nova to Participate in Upcoming Investor Conferences
-
Purpose Investments Inc. Confirms 2025 Final Capital Gains Distributions for Purpose Tactical Asset Allocation Fund, Purpose Core Equity Income Fund, and Purpose Tactical Thematic Fund
-
ModelOp Appoints Dave Trier to CEO As It Enters Next Phase of Growth
-
Southeast U.S. Leader Judge PR Launches AI-Powered Marketing Service - Backed by a Creative Team with 20+ Emmy Awards - to Dominate Google, AI Searches, and Regional Markets
-
PROG Holdings Reports Fourth Quarter 2025 Results
-
Osteria da Fortunata continues to strengthen its presence in Miami Beach more than two years after opening
-
First Patients Dosed in Alphyn Biologics' Phase 2 Trial of First-in-Class Topical Therapeutic for Molluscum Contagiosum
-
V2X Awarded ATSP5 Contract to Advance Emerging Technology for the Warfighter
-
JLL Reports 2025 Financial Results for Fourth Quarter and Full Year
-
BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care
-
Clean Harbors Announces Fourth-Quarter and Full-Year 2025 Financial Results
-
Nayax Announces Global Partnership with DC Fast Charger OEM Tritium to Simplify EV Charger Payment Enablement
-
Jensen Partners Named Recruitment Company of the Year: Investor Relations & Asset Raising at the 2026 Private Equity Wire® European Awards
-
Sharon AI Announces Nasdaq Listing and Pricing of $125 Million U.S. Initial Public Offering
-
Delta Galil Reports Fourth Quarter and Full Year 2025 Results
-
Starlab Space Announces Partnership with Helogen to Advance Life Sciences Research in Microgravity
-
BrightView Expands Golf Course Management Partnership with The Villages®
-
Zywave Unveils Winter 2026 Release to Help Brokers Win More Deals Faster
-
Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil
-
Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
-
Verde Clean Fuels, Inc. Announces Revised Strategy to Deploy Technology and Streamline Costs While Evaluating Strategic Alternatives
-
Terra Clean Closes the Acquisition to Earn 100% Interest in the Prospector & Freedom Uranium Mines in Marysvale, Utah, United States
-
NervGen Pharma to Participate at Upcoming Investor Conferences
-
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
-
Medicenna Therapeutics Announces Participation in Upcoming Conferences
-
Creative Realities Announces Repurchase of Slipstream Warrants
-
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
-
General Counsel Report Finds Legal Leaders Facing Increased Complexity, Unpredictability, Regulatory Activity and Costs
